The 'Ladies First' rapper has partnered with Novo Nordisk to create more awareness around obesity and cardiovascular disease.

Glucagon-like peptide-1 receptor agonists may cut the risk of obesity-related cancer in patients being treated for diabetes and obesity.

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...